NASDAQ · RGC
Healthcare · Drug Manufacturers - Specialty & Generic
$5.46
Up+$0.11 (+2.06%)
Updated Aug 19, 2026, 8:31 AM
SID Score
3.8/10
Composite research score
Smart Money
56/100
Neutral
Price performance
1M range · 21 trading sessions · Daily adjusted prices
RGC closed at $5.46 after 21 trading sessions, down 9.90% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $5.32 | $5.54 | $5.2194 | $5.46 | 88.75K |
| Aug 17, 2026 | $5.40 | $5.55 | $5.10 | $5.35 | 185.23K |
| Aug 14, 2026 | $5.24 | $5.55 | $5.10 | $5.45 | 132.28K |
| Aug 13, 2026 | $5.08 | $5.37 | $5.06 | $5.24 | 166.47K |
| Aug 12, 2026 | $5.10 | $5.35 | $5.02 | $5.06 | 187.33K |
| Aug 11, 2026 | $5.33 | $5.36 | $4.91 | $5.02 | 235.6K |
| Aug 10, 2026 | $5.52 | $5.68 | $5.20 | $5.28 | 204.03K |
| Aug 7, 2026 | $5.48 | $5.75 | $5.2401 | $5.41 | 191.88K |
| Aug 6, 2026 | $5.96 | $5.96 | $5.40 | $5.46 | 169.98K |
| Aug 5, 2026 | $6.01 | $6.228 | $5.66 | $5.87 | 301.18K |
| Aug 4, 2026 | $6.31 | $6.40 | $5.90 | $6.05 | 231.89K |
| Aug 3, 2026 | $6.06 | $6.75 | $5.955 | $6.13 | 293.36K |
| Jul 31, 2026 | $5.93 | $6.20 | $5.6275 | $6.18 | 191.79K |
| Jul 30, 2026 | $5.76 | $6.15 | $5.59 | $5.94 | 175.47K |
| Jul 29, 2026 | $5.97 | $6.35 | $5.585 | $5.65 | 174.45K |
| Jul 28, 2026 | $5.67 | $6.08 | $5.33 | $5.97 | 164.1K |
| Jul 27, 2026 | $5.72 | $6.1986 | $5.63 | $5.83 | 202.33K |
| Jul 24, 2026 | $5.63 | $5.82 | $5.33 | $5.72 | 162.16K |
| Jul 23, 2026 | $5.94 | $5.9908 | $5.57 | $5.62 | 156.75K |
| Jul 22, 2026 | $6.00 | $6.20 | $5.56 | $5.98 | 285.83K |
| Jul 21, 2026 | $5.23 | $6.30 | $5.16 | $6.06 | 582.15K |
The latest Smart Investors Daily articles mentioning RGC.
RGC research
Company profile and research snapshot.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Jul 8, 2026
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $2.5 million. Tvardi Therapeutics (NASDAQ:TVRD)
ChartMill · Jul 6, 2026
Unusual volume stocks are being observed in Monday's session.
SeekingAlpha · Jul 6, 2026
Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant treatment gaps.
SeekingAlpha · Mar 6, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RGC.
